IDO-1 appeared only once among our included breast cancer articles, in a study where researchers analyzed the immunogenomic profiling and pathological response to neoadjuvant therapy including docetaxel and carboplatin, both commonly used in the treatment for breast cancer. Here, IDO1 is linked to breast cancer.